Strategic insights for MSMEs: navigating the new normal with big data and business analytics

Abstract

Purpose

The purpose of this paper is to manage knowledge pertaining to micro, small and medium enterprise (MSME) actors in the business, agriculture and industry sectors. This study uses text mining techniques, specifically Latent Dirichlet Allocation Mallet, to analyze the data obtained from the in-depth interviews. This analysis helps us identify and understand the issues faced by these actors.

Design/methodology/approach

In this study, the authors use big data and business analytics to recalculate the MSME business vulnerability index in 503 districts and 34 provinces across Indonesia. Subsequently, the authors conduct in-depth interviews with MSME actors in Medan, Central Java, Yogyakarta, Bali and Manokwari, West Papua. Through these interviews, the authors explore their strategies for surviving the COVID-19 pandemic and the extent of their digital literacy, and the application of technology to maximize sales and business outcomes.

Findings

The findings reveal that, for the sustainable growth of MSMEs during and after the pandemic, collaboration across the Penta-Helix framework is essential. This collaboration enables the development of practical solutions for the challenges posed by COVID-19, particularly in the context of the “new normal.” In addition, the authors’ survey of MSMEs involved in agriculture, trade and processing sectors demonstrates that 58.33% experienced a decrease in income during the pandemic and 12.66% reported an increase in revenue. In contrast, 25% experienced no change in income before and during the pandemic.

Originality/value

This research contributes significantly by offering comprehensive insights obtained from in-depth surveys conducted with MSMEs across multiple sectors. The findings underscore the importance of addressing the challenges MSMEs face and highlight the need for collaboration within the Penta-Helix framework to foster their resilience and success amidst the COVID-19 pandemic.